Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-06-18

FDA Approved: RILUZOLE — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical's riluzole via an original application as a generic product for the treatment of amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Riluzole (riluzole)

Snippet

ORIG AP for RILUZOLE (RILUZOLE)